• Can AI Fix Prior Authorization?
    Nov 17 2026

    Artificial intelligence is reframing prior authorization and health insurance decision-making.

    In this episode, Dr. Michelle Mello of Stanford University joins A Health Podyssey to discuss how insurers and providers are using AI to review coverage requests, process appeals, and manage utilization review.

    They explore the promise of faster, more efficient decisions, as well as growing concerns about transparency, bias, human oversight, and patient access to care.

    Order the January 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

    Show More Show Less
    27 mins
  • Nonprofit Hospitals Get Billions in Tax Breaks. What Do Patients Get Back?
    Nov 10 2026

    Nonprofit hospitals receive substantial tax advantages in exchange for providing benefits to the communities they serve. But how well is that system working in practice?

    In this episode, Tatiane Santos discusses new research on hospital charity care, financial assistance programs, and the wide variation in how nonprofit hospitals support patients facing medical bills. The conversation explores who qualifies for assistance, why access to charity care differs across hospitals and states, and what policymakers should consider as scrutiny of nonprofit hospital tax exemptions grows.

    The conversation also examines the broader debate over accountability, community benefit requirements, and whether nonprofit hospitals are delivering sufficient value in return for the public subsidies they receive.

    Order the November 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

    Show More Show Less
    23 mins
  • How Stimulants Are Reshaping the Overdose Crisis | SPONSORED
    Nov 4 2026

    THIS SPONSORED PODCAST IS BROUGHT TO YOU BY THE COBRE ON OPIOIDS AND OVERDOSE AT RHODE ISLAND HOSPITAL.

    The US overdose crisis is changing. While opioid-related overdose deaths have begun to decline, researchers are seeing a growing role for stimulants, including cocaine and methamphetamine, in overdose risk.

    In this sponsored episode, Leslie Erdelack speaks with Dr. Jaclyn White Hughto from Brown University about what researchers are learning from the evolving overdose epidemic. They discuss findings from the POINTS (Preventing Overdoses Involving Stimulants) study, a CDC-funded project examining stimulant-involved overdoses in Massachusetts and Rhode Island.

    The conversation explores:

    • How the US overdose epidemic has evolved, from prescription opioids to fentanyl and stimulant involvement
    • Why stimulant-involved overdoses differ from opioid overdoses
    • The rise of stimulant-only overdose deaths
    • What researchers learned from interviews with people who use drugs
    • Misconceptions about fentanyl contamination in the stimulant supply
    • How people who use stimulants perceive and manage overdose risk
    • The role of fentanyl test strips, naloxone, and other harm-reduction tools
    • Community-driven strategies to improve overdose prevention
    • Challenges surrounding Good Samaritan laws and emergency response
    • Why surveillance data and public health monitoring remain critical
    • New research examining potent stimulants and opportunities for earlier intervention

    Dr. Hughto also discusses ongoing NIH-funded research aimed at understanding rising stimulant-only overdoses and identifying ways policymakers, clinicians, and communities can respond more effectively.

    RELATED LINKS:

    • The Center of Biomedical Research Excellence on Opioids and Overdose
    • The POINTS (Preventing Overdoses Involving Stimulants) study
    Show More Show Less
    31 mins
  • Medicare Is Moving Surgeries Out of Hospitals (And Possibly Saving Billions) | David Howard
    Nov 3 2026

    What happens when Medicare stops requiring certain surgeries to be performed in hospitals?

    In this episode of A Health Podyssey, host Rob Lott speaks with David H. Howard about new research estimating that removing procedures from Medicare’s inpatient-only list shifted care to outpatient settings and reduced spending by billions of dollars. The paper raises important questions about patient care, hospital incentives, and the future of Medicare payment policy.

    Order the November 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

    Show More Show Less
    19 mins
  • Do Provider-Owned Health Plans Lower Healthcare Costs? New Evidence on Vertical Integration | Mitchell Mead
    Oct 27 2026

    This episode is brought to you by Semafor Healthcare.

    Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.


    Hospital systems are increasingly becoming both providers and insurers, but what does that mean for healthcare prices?

    In this episode of A Health Podyssey, host Rob Lott speaks with University of Michigan's Mitchell Mead about his new Health Affairs research examining whether provider-sponsored health plans negotiate healthcare prices differently than traditional insurers.

    Drawing on hospital price transparency data and national health system datasets, Mead explains how vertically integrated payer-provider organizations have grown since the Affordable Care Act and why Medicare Advantage has become a major driver of that trend. The discussion explores the finding that provider-sponsored health plans negotiated lower prices for 44 of 46 healthcare services studied.

    The conversation also examines what these findings mean for policymakers grappling with healthcare affordability, consolidation, antitrust oversight, and the future of vertically integrated healthcare organizations.

    Order the October 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.


    Subscribe to Semafor Healthcare for free.

    Show More Show Less
    22 mins
  • The Real Savings From Generic Drugs: What Medicare Part D Data Reveals | CBO's Scott Laughery
    Oct 20 2026

    This episode is brought to you by Semafor Healthcare.

    Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.


    Health Affairs Publishing’s Rob Lott speaks to Scott Laughery of the Congressional Budget Office about new research examining how generic drug entry affects net prescription drug prices and spending in Medicare Part D.

    Their conversation explores the often-hidden role of rebates, how generic competition reshapes drug markets, and what newly available data reveal about savings after loss of exclusivity.


    Order the October 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.


    Subscribe to Semafor Healthcare for free.

    Show More Show Less
    22 mins
  • Why Prior Authorization Still Frustrates Everyone: DrFirst's Colin Banas on What's Changing | SPONSORED
    Oct 15 2026

    THIS SPONSORED PODCAST EPISODE IS BROUGHT TO YOU BY DrFIRST.

    In this sponsored episode, Dr. Colin Banas, chief medical officer at DrFirst, joins Health Affairs Publishing's Rob Lott to discuss prior authorization, why the process continues to create delays and administrative burden, and the future of prior authorization in the health care ecosystem.

    Colin Banas joined DrFirst in 2019 after spending 17 years as CMIO at VCU Health System, where he also practiced as an internal medicine hospitalist. He has testified before the U.S. Senate on health IT and meaningful use and previously served as a health IT Fellow at the ONC.

    At DrFirst, Dr. Banas drives innovation in medication workflows, focusing on non-disruptive decision support that creates better experiences for providers and patients, including how AI can reduce clinical burnout and improve patient outcomes.

    This conversation explores the root causes of prior authorization challenges, from fragmented workflows and outdated technology to the competing incentives facing providers and payers. Dr. Banas and Lott also discuss how automation, interoperability, and artificial intelligence are beginning to reshape prior authorization and help organizations reduce friction while maintaining appropriate oversight of care.

    Show More Show Less
    35 mins
  • Diagnosing Dementia: Confidence Gaps Across the Health Care Workforce
    Oct 13 2026

    Health Affairs Publishing’s Rob Lott speaks to Sumedha Gupta of Indiana University about new research on the dementia care workforce and how clinician experiences vary across provider types. They examine what those differences could mean for access, diagnosis, and care as dementia prevalence increases in the years ahead.


    Order the October 2026 issue of Health Affairs.

    Sign up for our free Health Affairs newsletters to stay up to date on health policy news and analysis.

    Show More Show Less
    17 mins